NWAM LLC’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,500	Closed	-$82.9K	–	520
2024 Q4	$82.9K	Buy	15,500 +5,450	+54%	+$29.2K	0.01%	584
2024 Q3	$53.1K	Buy	+10,050	New	+$53.1K	﹤0.01%	614